IMMUNITY THAT'S MORE THAN SKIN DEEP
Overview
Management Team
Board of Directors
Contact
Overview
Travelers' Diarrhea
Pandemic Influenza
Influenza/Other Programs
Overview
How TCI Works
Features & Advantages
Publications
Overview
Stock Quote
Stock Chart
Annual Reports
Analysts
SEC Filings
Presentations
Press Releases
Calendar of Events
Email Alerts
Overview
Opportunities
TRAVELERS' DIARRHEA
Learn more about the prevention of travelers' diarrhea caused by enterotoxigenic E. coli bacteria (ETEC).
Pandemic (Avian) Flu
Learn more about immunostimulant (IS) patches for use with vaccines for pandemic influenza.
Influenza/Other Programs
Learn about Iomai's needle-free influenza vaccine programs and other efforts leveraging the Iomai patch technology.
IOMAI'S VACCINE PATCHES
Needle-free
Possible self-application
Mailable
Stable
Iomai In the News
04.15.08
Iomai Receives HHS Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch
04.08.08
Iomai Wins Department of Defense Grant to Develop a Stable, Patch-Based Anthrax Vaccine
04.03.08
Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch
more news
Site Design: Formative
|
Legal Disclaimer
|
Site Map
|
Terms & Conditions
|
Contact Us
|
© 2007 Iomai Corporation
TRAVELERS' DIARRHEA
